vs
Amarin Corp plc（AMRN）与CANTALOUPE, INC.（CTLP）财务数据对比。点击上方公司名可切换其他公司
CANTALOUPE, INC.的季度营收约是Amarin Corp plc的1.7倍（$78.7M vs $45.1M），CANTALOUPE, INC.净利率更高（-0.1% vs -23.3%，领先23.2%），Amarin Corp plc同比增速更快（7.0% vs 6.8%），过去两年CANTALOUPE, INC.的营收复合增速更高（7.7% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
坎塔卢波（原美国技术公司）是一家美国科技企业，核心业务为ePort无现金支付受理技术，依托持专利的PCI合规ePort Connect服务开展运营。该服务可通过无线方式为消费者提供信用卡、借记卡以及Apple Pay、Google Pay等NFC钱包支付选项，同时为运营商提供遥测与机器间通信服务，ePort技术主要应用于...
AMRN vs CTLP — 直观对比
营收规模更大
CTLP
是对方的1.7倍
$45.1M
营收增速更快
AMRN
高出0.2%
6.8%
净利率更高
CTLP
高出23.2%
-23.3%
两年增速更快
CTLP
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $78.7M |
| 净利润 | $-10.5M | $-70.0K |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | 2.0% |
| 净利率 | -23.3% | -0.1% |
| 营收同比 | 7.0% | 6.8% |
| 净利润同比 | 33.0% | -101.4% |
| 每股收益（稀释后） | — | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNCTLP
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $78.7M | ||
| Q3 25 | $49.7M | $80.9M | ||
| Q2 25 | $72.7M | $82.6M | ||
| Q1 25 | $42.0M | $75.4M | ||
| Q4 24 | $62.3M | $73.7M | ||
| Q3 24 | $42.3M | $70.8M | ||
| Q2 24 | $67.5M | $72.7M |
净利润AMRNCTLP
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $-70.0K | ||
| Q3 25 | $-7.7M | $-919.0K | ||
| Q2 25 | $-14.1M | $6.8M | ||
| Q1 25 | $-15.7M | $49.2M | ||
| Q4 24 | $-48.6M | $5.0M | ||
| Q3 24 | $-25.1M | $3.6M | ||
| Q2 24 | $1.5M | $2.2M |
毛利率AMRNCTLP
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNCTLP
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 2.0% | ||
| Q3 25 | -22.4% | 2.0% | ||
| Q2 25 | -22.0% | 6.3% | ||
| Q1 25 | -39.9% | 9.1% | ||
| Q4 24 | -84.3% | 8.4% | ||
| Q3 24 | -59.5% | 5.8% | ||
| Q2 24 | -0.8% | 4.9% |
净利率AMRNCTLP
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | -0.1% | ||
| Q3 25 | -15.6% | -1.1% | ||
| Q2 25 | -19.4% | 8.3% | ||
| Q1 25 | -37.4% | 65.2% | ||
| Q4 24 | -78.0% | 6.7% | ||
| Q3 24 | -59.4% | 5.0% | ||
| Q2 24 | 2.3% | 3.0% |
每股收益（稀释后）AMRNCTLP
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.00 | ||
| Q3 25 | $-0.02 | $-0.02 | ||
| Q2 25 | $-0.03 | $0.10 | ||
| Q1 25 | $-0.04 | $0.65 | ||
| Q4 24 | $-0.12 | $0.07 | ||
| Q3 24 | $-0.06 | $0.04 | ||
| Q2 24 | $0.00 | $0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $53.0M |
| 总债务越低越好 | — | $37.7M |
| 股东权益账面价值 | — | $252.5M |
| 总资产 | $645.8M | $381.9M |
| 负债/权益比越低杠杆越低 | — | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资AMRNCTLP
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $53.0M | ||
| Q3 25 | $286.6M | $55.0M | ||
| Q2 25 | $298.7M | $51.1M | ||
| Q1 25 | $281.8M | $46.3M | ||
| Q4 24 | $294.2M | $27.7M | ||
| Q3 24 | $305.7M | $33.1M | ||
| Q2 24 | $306.7M | $58.9M |
总债务AMRNCTLP
| Q1 26 | — | — | ||
| Q4 25 | — | $37.7M | ||
| Q3 25 | — | $38.3M | ||
| Q2 25 | — | $38.7M | ||
| Q1 25 | — | $39.2M | ||
| Q4 24 | — | $37.0M | ||
| Q3 24 | — | $37.3M | ||
| Q2 24 | — | $37.5M |
股东权益AMRNCTLP
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $252.5M | ||
| Q3 25 | $458.9M | $251.8M | ||
| Q2 25 | $464.9M | $251.0M | ||
| Q1 25 | $473.7M | $240.7M | ||
| Q4 24 | $486.2M | $190.1M | ||
| Q3 24 | $531.4M | $186.2M | ||
| Q2 24 | $551.9M | $181.7M |
总资产AMRNCTLP
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $381.9M | ||
| Q3 25 | $659.8M | $389.5M | ||
| Q2 25 | $670.1M | $381.9M | ||
| Q1 25 | $655.7M | $370.5M | ||
| Q4 24 | $685.3M | $303.0M | ||
| Q3 24 | $750.6M | $312.1M | ||
| Q2 24 | $799.9M | $335.6M |
负债/权益比AMRNCTLP
| Q1 26 | — | — | ||
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $3.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-614.0K |
| 自由现金流率自由现金流/营收 | — | -0.8% |
| 资本支出强度资本支出/营收 | — | 4.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $25.8M |
8季度趋势，按日历期对齐
经营现金流AMRNCTLP
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $3.1M | ||
| Q3 25 | $-12.7M | $7.0M | ||
| Q2 25 | $16.6M | $9.4M | ||
| Q1 25 | $-12.5M | $22.4M | ||
| Q4 24 | $-13.3M | $522.0K | ||
| Q3 24 | $-2.4M | $-12.0M | ||
| Q2 24 | $-2.7M | $14.3M |
自由现金流AMRNCTLP
| Q1 26 | — | — | ||
| Q4 25 | — | $-614.0K | ||
| Q3 25 | — | $3.5M | ||
| Q2 25 | — | $4.3M | ||
| Q1 25 | — | $18.6M | ||
| Q4 24 | — | $-3.8M | ||
| Q3 24 | — | $-15.8M | ||
| Q2 24 | — | $8.5M |
自由现金流率AMRNCTLP
| Q1 26 | — | — | ||
| Q4 25 | — | -0.8% | ||
| Q3 25 | — | 4.4% | ||
| Q2 25 | — | 5.3% | ||
| Q1 25 | — | 24.6% | ||
| Q4 24 | — | -5.1% | ||
| Q3 24 | — | -22.3% | ||
| Q2 24 | — | 11.7% |
资本支出强度AMRNCTLP
| Q1 26 | — | — | ||
| Q4 25 | — | 4.8% | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | — | 6.2% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 5.8% | ||
| Q3 24 | — | 5.4% | ||
| Q2 24 | — | 7.9% |
现金转化率AMRNCTLP
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.38× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | -3.36× | ||
| Q2 24 | -1.81× | 6.47× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
CTLP
| Transaction Processing | $47.9M | 61% |
| Subscription Revenue | $21.8M | 28% |
| Products | $9.0M | 11% |
